Unveiling the immunomodulatory mechanism of polysaccharides from Polygonum cyrtonema based on RNA-seq.
JAK-STAT
MAPKs
NF-κB
Polygonatum cyrtonema polysaccharide
RNA-seq
Journal
Food research international (Ottawa, Ont.)
ISSN: 1873-7145
Titre abrégé: Food Res Int
Pays: Canada
ID NLM: 9210143
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
26
08
2023
revised:
04
11
2023
accepted:
22
11
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
21
12
2023
Statut:
ppublish
Résumé
This work aimed to illuminate the mechanism of Polygonatum cyrtonema polysaccharide (PCP-80%) triggered immune activation. Results showed that PCP-80% enhanced the protein expression of COX-2 and iNOS, along with increasing the release of NO, ROS, cytokines (TNF-α, IL-6) in RAW264.7 cells. RNA-seq analysis revealed 2160 differentially expressed genes (DEGs) following PCP-80% treatment, comprising 1142 up-regulated and 1018 down-regulated genes. In addition, for investigating possible regulatory mechanisms, the NF-κB, MAPKs, and JAK-STAT signaling pathways were also chosen based on bioinformatics analysis. Furthermore, these findings were further corroborated through Western blot experiments, validating the activation of JAK-STAT (reduction of JAK1 in cells and elevation of p-STAT3 in the nucleus), MAPK (elevation of p-p38, p-ERK1/2, and p-JNK), and NF-κB (elevation of p-IκBα in cells, reduction of cytoplasmic p65, and increase of nuclear content of p-p65) in macrophage activation induced by PCP-80%. Besides, the production of NO and TNF-α was decreased by the inhibitor of the three pathways. In conclusion, these findings provide strong evidence that PCP-80% effectively modulates the immune response of macrophages, with significant involvement of the JAK-STAT, MAPKs, and NF-κB signaling pathways.
Identifiants
pubmed: 38129053
pii: S0963-9969(23)01303-0
doi: 10.1016/j.foodres.2023.113755
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113755Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.